Gene · 29968
PSAT1: phosphoserine aminotransferase 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. PSAT1: phosphoserine aminotransferase 1. Genes, record 29968. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/29968
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9Y617 | Phosphoserine aminotransferase | 370 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents80
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026082974 A | 2026-05-19 | 144 | Q9Y617 | Espacenet |
| JP 2026067851 A | 2026-04-21 | 325 | Q9Y617 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 58047 | Q9Y617 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 9802 | Q9Y617 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 5662 | Q9Y617 | Espacenet |
| JP 2025535559 A | 2025-10-24 | 1 | Q9Y617 | Espacenet |
| EP 4611794 A1 | 2025-09-10 | 1 | Q9Y617 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 9802 | Q9Y617 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 5662 | Q9Y617 | Espacenet |
| JP 2023123507 A | 2023-09-05 | 150 | Q9Y617 | Espacenet |
1 to 10 of 80
See all 80 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,216
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PSAT1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 18 | 2025 |
| P01CA120964 | Molecular Pathogenesis of the Hamartoma Syndromes | 11 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 9 | 2025 |
| P01CA117969 | Genetics and Biology of Pancreatic Ductal Adenocarcinoma | 7 | 2025 |
| P30CA006516 | Dana-Farber/Harvard Cancer Center | 5 | 2025 |
| P30CA072720 | Cancer Center Support Grant | 5 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 4 | 2025 |
| P30CA013696 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 4 | 2025 |
| P30CA042014 | Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,216Source NIH's project files
See all 1,216 nih grantsPapers1,996
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Statement of Retraction: Examination of the effects of microRNA-145-5p and phosphoserine aminotransferase 1 in colon cancer. | Bioengineered | 2026 | 42820759 | PubTator, text mining | PubMed |
| Real-world insights into genomic reprogramming during CAR-T cell manufacturing in India. | Front Immunol | 2026 | 42756106 | PubTator, text mining | PubMed |
| Genomic diversification between aposematic and cryptic phenotypes of Oophaga granulifera (Anura: Dendrobatidae). | Sci Rep | 2026 | 42661044 | PubTator, text mining | PubMed |
| Polyamines buffer labile iron to suppress ferroptosis. | Cell | 2026 | 42600612 | PubTator, text mining | PubMed |
| Macrophage-to-myofibroblast transition-derived itaconate promotes bone metastasis in lung cancer through targeting of HSPA8. | Exp Mol Med | 2026 | 42557310 | PubTator, text mining | PubMed |
| A Three-Gene Prognostic Signature Driven by an ER Stress-Associated ceRNA Network: Integrating Single-Cell Transcriptomics and Cross-Platform Validation in Hepatocellular Carcinoma. | Curr Issues Mol Biol | 2026 | 42510982 | PubTator, text mining | PubMed |
| One-carbon metabolism upregulated in lupus promotes the differentiation and effector functions of human B and T cells. | Rheumatology (Oxford) | 2026 | 42490203 | PubTator, text mining | PubMed |
| Comprehensive analysis of the association between perfluorooctanoic acid exposure and osteosarcoma progression. | Food Chem Toxicol | 2026 | 42462996 | PubTator, text mining | PubMed |
| Circulating mRNA and miRNA Signatures Used as Predictive Markers of Lifestyle Modification Outcomes in Pediatric Obesity Management. | Horm Res Paediatr | 2026 | 42391183 | PubTator, text mining | PubMed |
| Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stability. | Drug Resist Updat | 2026 | 42364255 | PubTator, text mining | PubMed |
1 to 10 of 1,996
See all 1,996 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/29968
GET https://conductscience.org/api/genes/v1/29968/patents?page=2